China SXT Pharmaceuticals, Inc. SXTC
Set alert
At close · Nov 2
After hours · Nov 2, 5:20 PM ET
- YTD
- -100.00%
- 1 year
- -100.00%
- Open
- 3.12
- Prev close
- 3.25
- Mkt cap
- 287.94K
- Vol
- 71.82K
- Avg vol
- 224.22K
- EPS
- -73,040.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.77
- High
- 3.12
- Forward P/E
- 0.00
- Beta
- 1.16
- Short ratio
- 0.52
- Inst. own
- 1.35%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.47092
- 200-d avg
- 0.939895
- 1y target
- 0.00
1Y chart
Events in this range
- Feb 3, 2026Split: 1 for 150
- Aug 10, 2026Split: 1 for 80
- Oct 26, 2026Split: 1 for 100
Signals (32)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| RSI: Oversold | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| RSI: Oversold | May 12, 2026 | 5 months ago |
| RSI: Oversold | May 7, 2026 | 5 months ago |
| SMA: Bearish | May 5, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 9, 2026 | 9 months ago |
| RSI: Oversold | Jan 9, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| RSI: Overbought | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 6, 2026 | 10 months ago |
| SMA: Bullish | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 31, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 30, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 30, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Nov 19, 2025 | 11 months ago |
| SMA: Bullish | Nov 18, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 18, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 12 months ago |
| SMA: Bullish | Nov 5, 2025 | 12 months ago |
Key statistics
- Market cap
- 1.41M
- Enterprise value
- -7.26M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.73
- Price / book
- 0.06
- EPS (TTM)
- -3.57
- Beta
- 1.16
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -160.67%
- Revenue (TTM)
- 1.93M
- Revenue growth
- 29.50%
- Free cash flow
- -1.22M
- Total cash
- 12.07M
- Total debt
- 3.70M
- Return on equity
- -21.65%
- Shares outstanding
- 4.06M
- Short % of float
- 1.84%
- 50-day average
- 0.47092
- 200-day average
- 0.939895
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- China
- Website
- sxtchina.com
News
- China SXT Pharmaceuticals Announces 1-For-100 Reverse Stock Split, Effective Oct. 26
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- China SXT Pharmaceuticals, Inc. Announces Share Consolidation
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Dow Gains Over 200 Points; GE Aerospace Posts Upbeat Earnings
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's After-Market Session
Your note
Sign in to keep a note on SXTC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baader Bank Aktiengesellschaft | 0.37% | 15,161 | 5.26K | Sep 29, 2024 |
| Gsa Capital Partners Llp | 0.30% | 12,300 | 4.26K | Sep 29, 2024 |
| Bank of Montreal /CAN/ | 0.25% | 10,000 | 3.47K | Sep 29, 2024 |
| UBS Group AG | 0.21% | 8,678 | 3.01K | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.01% | 376 | 130 | Sep 29, 2024 |
| Acadian Asset Management. LLC | 0.01% | 379 | 131 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.00% | 54 | 18 | Oct 30, 2023 |